Régis Bataille

CD130 rather than CD126 expression is associated with disease activity in multiple myeloma

Philippe Moreau, R. Bataille, M. Amiot, 1999, British journal of haematology.

Advances in Biology and Therapy of Multiple Myeloma

Bart Barlogie, Joth Jacobson, R. Bataille, 2013, Springer New York.

Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen

Catherine Charbonnel, Wilfried Gouraud, Pascal Jézéquel, 2008, Breast Cancer Research and Treatment.

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Kenneth C. Anderson, Benjamin Djulbegovic, Bart Barlogie, 2003, British journal of haematology.

A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

J. Rossi, R. Bataille, N. Ifrah, 1996 .

14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.

Laurence Lodé, Richard Garand, R. Bataille, 2003, Seminars in oncology.

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Augustin Ferrant, Chantal Doyen, J. Rossi, 2006 .

Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myélome.

Laurence Lodé, Catherine Charbonnel, Wilfried Gouraud, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.